Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
La ribonucleoprotein domain family member 1B (LARP1B) is a member of the La-related protein family of RNA-binding proteins, which are involved in various aspects of RNA metabolism. LARP1B shares significant sequence homology with LARP1, including the presence of a La domain, an RNA recognition motif, and a DM15 region. LARP1B has been implicated in the regulation of mRNA translation, impacting cell growth, differentiation, and proliferation[1][3]. Recent research suggests that circular RNA isoforms of the LARP1B gene (circ-LARP1B) act as regulators in cancer, specifically by sponging microRNAs to modulate oncogenic pathways, highlighting its emerging role in oncogenesis[3]. Detailed mechanistic roles of LARP1B in translation or disease remain less well studied than those of LARP1, but it is considered a potential therapeutic target due to its involvement in mRNA regulation and cancer biology.
Not well established for LARP1B specifically; other family members modulate translation via cap-binding and displacement of eIF4E from mRNA[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on La ribonucleoprotein domain family member 1B (LARP1B).